Oct 21, 2017 | Latest News
Treatments for cancer, arthritis and multiple sclerosis (MS) are among drugs costing the cash-strapped NHS over a billion pounds a year – despite public funding playing a substantial role in the medicines’ development. The new report, Pills and Profits: How drug...
